The global in
vitro diagnostics (IVD) market size is expected to reach USD 97.01
billion by 2022, according to a new report by Grand View Research, Inc., rising
at a CAGR of 6.8% during the forecast period. Increasing incidence of sexually
transmitted and gastrointestinal diseases coupled with surging demand for
large-scale screening, particularly for cancer, is stimulating the growth of
the market. IVD helps in detecting whether a particular medicine or treatment
would work on a patient.
Constant innovations and advancements play a pivotal
role in the development of the market. IVD is being increasingly used in every
stage of the patient care and nearly each healthcare setting. Though, most of
these tests are remotely performed, making their presence unnoticed.
Various organizations are functioning to monitor the
market. For instance, BIVDA is an association of companies with high
involvement and interest and represents manufacturers and distributors
functioning in the U.K.
Rapidly changing healthcare environment and growing
acknowledgment of diagnostics role in patient care, along with rising awareness
regarding importance of early diagnosis of chronic diseases, are likely to
boost the growth of the IVD market.
Surging demand for point-of-care detection and
identification of various infectious diseases such respiratory tract
infections, including Legionnaires’ disease, RSV, influenza, and pneumonia,
coupled with pathogens causing filariasis and malaria, is providing a
significant push to the market.
Browse full research report on In Vitro Diagnostics (IVD) Market: https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-market
Further
key findings from the report suggest:
- Reagents were the largest segment in 2016 and are expected to show
the fastest growth over the forecast period owing to rising R&D
activities pertaining to self-test and point-of-care products
- Infectious disease dominated the market in 2016 due to increasing
incidence of infectious diseases such as pneumonia, tuberculosis, and HIV.
- Hospitals were one of the largest segment in 2016 owing to rising
number of hospitalized patients
- North America dominated the IVD market in 2016 due to rising
prevalence of chronic disorders such as respiratory diseases and cancer in
this region
- Asia Pacific is expected to be the fastest growing region over the
forecast period. Rising per capita healthcare expenditure, government
initiatives, and growing clinical research activities for advanced
diagnostics are likely to drive the regional market.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/healthcare
Grand
View Research has segmented the global in vitro diagnostics market report on
the basis of technology, application, and region:
In
Vitro Diagnostics Product Outlook (Revenue, USD Million, 2013 - 2022)
- Instruments
- Reagents
- Software
In
Vitro Diagnostics Application Outlook (Revenue, USD Million, 2013 - 2022)
- Infectious
Disease
- Diabetes
- Cancer
- Cardiology
- Nephrology
- Autoimmune
Diseases
- Drug Testing
- Others
In
Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2013 - 2022)
- Immunology
- Hematology
- Clinical
Chemistry
- Molecular
Diagnostics
- Coagulation
- Microbiology
- Others
In
Vitro Diagnostics End-use Outlook (Revenue, USD Million, 2013 - 2022)
- Hospital
- Laboratory
- Home Care
- Others
In
Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2022)
- North America
- Europe
- Asia Pacific
- RoW
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment